Qube Research & Technologies (QRT)’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-35,277
Closed -$370K 4999
2023
Q4
$370K Sell
35,277
-84,077
-70% -$1.03M ﹤0.01% 2463
2023
Q3
$1.57M Sell
119,354
-185,529
-61% -$2.43M ﹤0.01% 1512
2023
Q2
$3.84M Buy
304,883
+45,699
+18% +$555K 0.01% 781
2023
Q1
$3.38M Buy
259,184
+29,703
+13% +$481K 0.01% 789
2022
Q4
$4.05M Buy
229,481
+7,548
+3% +$126K 0.02% 719
2022
Q3
$3.38M Buy
221,933
+55,048
+33% +$890K 0.02% 728
2022
Q2
$2.48M Buy
+166,885
New +$3.12M 0.02% 730
2021
Q4
Sell
-94,712
Closed -$1.27M 3081
2021
Q3
$1.27M Buy
94,712
+80,147
+550% +$1.29M 0.02% 822
2021
Q2
$270K Sell
14,565
-27,282
-65% -$459K ﹤0.01% 1637
2021
Q1
$628K Buy
+41,847
New +$670K 0.01% 1049
2018
Q4
Sell
-6,079
Closed -$87K 957
2018
Q3
$87K Buy
6,079
+4,426
+268% +$60.1K 0.01% 796
2018
Q2
$20K Buy
+1,653
New +$20.4K 0.01% 713

Other funds holding MDRX

Qube Research & Technologies (QRT)'s MDRX Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 35,277 shares — an estimated $370K sold.

Qube Research & Technologies (QRT) first reported a position in MDRX in Q2 2018 and held it in 12 quarters. The position peaked at $4.05M in Q4 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 35,277 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $370K.
  • Qube Research & Technologies (QRT) first reported a position in Veradigm Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s Veradigm Inc. Common Stock position peaked at $4.05M in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.